Japan First in the World to Approve Dupixent® (dupilumab) for Chronic Spontaneous Urticaria (CSU)
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan…
Tag: Asthma
EAACI Pediatric Allergy and Asthma Meeting 2023: Shaping the Future of Pediatric Allergy and Asthma Care
The Organizing Committee is thrilled to announce the eagerly anticipated EAACI Pediatric Allergy and Asthma Meeting (PAAM) 2023, scheduled to…
Embracing Change: The “Stop Sneeze to Wheeze” Initiative’s Pioneering Approach to Allergic Rhinitis and Asthma Management
In a move that promises to reshape the landscape of respiratory health, Alkem Laboratories Ltd. launched the “Stop Sneeze to…
75% of Asthma Patients Have Worse Symptoms During Cold or Flu
Amid the ongoing cold waves of winters, smog and air pollution have resumed, thereby increasing the intensity of blocked airways…
11–14% of Children Aged 5 years & Older Currently Report Asthma Symptoms
Children are the most vulnerable and innocent members of the family and need special care and attention from elders. National…